Earnings History Data for Vera Therapeutics (VERA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Vera Therapeutics
Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20-03-2024 | PM | VERA | Vera Therapeutics | 2,177 | -0.58 | -0.53 | 0.00 | Vera Therapeutics GAAP EPS of -$2.25 misses by $0.07 [3/20/2024 3:01 PM] |
45.23 | 1.81 (4.18%) |
45.50 | 2.08 (4.79%) |
5.95 - 50.78 | 662,076 | 760,000 | 166 | ||
| 09-11-2023 | PM | VERA | Vera Therapeutics, Inc. | 458.25 | -0.45 | -0.50 | -0.91 | Vera Therapeutics GAAP EPS of -$0.45 beats by $0.08 [11/9/2023 1:15 PM] |
12.10 | 0.59 (5.13%) |
12.35 | 0.84 (7.30%) |
5.20 - 21.02 | 724,565 | 670,000 | 6,677 | ||
| 10-08-2023 | PM | VERA | Vera Therapeutics, Inc. | 796.70 | -0.46 | -0.69 | -0.55 | Vera Therapeutics GAAP EPS of -$0.46 beats by $0.23 [8/10/2023 12:05 PM] |
18.45 | -1.19 (-6.06%) |
19.64 | 0.0 (0.00%) |
5.20 - 23.39 | 311,537 | 390,000 | 4,326 | ||
| 11-05-2023 | PM | VERA | Vera Therapeutics | 338.00 | -0.80 | -0.59 | 0.00 | Vera Therapeutics GAAP EPS of -$0.80 misses by $0.20 [5/11/2023 12:12 PM] |
7.54 | -0.16 (-2.08%) |
0.0 | 0.0 (0.00%) |
5.20 - 23.39 | 317,049 | 280,000 | 0 | ||
| 28-03-2023 | PM | VERA | Vera Therapeutics | 208.00 | -1.19 | -0.93 | 0.00 | Vera Therapeutics GAAP EPS of -$3.35 misses by $0.34 [3/28/2023 7:54 AM] |
7.25 | -0.05 (-0.68%) |
0.0 | 0.0 (0.00%) |
5.20 - 24.94 | 295,183 | 590,000 | 0 | ||
| 10-08-2022 | PM | 7:30 AM ET (Aug 10) |
VERA | Vera Therapeutics | 487.00 | -0.55 | -0.72 | 0.00 | Vera Therapeutics GAAP EPS of -$0.55 beats by $0.17 [8/10/2022 8:12 AM] |
19.50 | 1.55 (8.64%) |
17.95 | 0.0 (0.00%) |
12.29 - 37.11 | 91,765 | 50,000 | 325 | |
| 16-05-2022 | PM | 6:30 AM ET (May 16) |
VERA | Vera Therapeutics | 388.00 | -0.71 | -0.67 | 0.00 | Vera Therapeutics GAAP EPS of -$0.71 misses by $0.07 [5/16/2022 9:47 AM] |
15.69 | 0.40 (2.58%) |
15.29 | 0.0 (0.00%) |
11.39 - 37.11 | 85,520 | 110,000 | 131,022 | |
| 24-03-2022 | PM | VERA | Vera Therapeutics, Inc. | 576.06 | -0.79 | -0.49 | 0.00 | Vera Therapeutics GAAP EPS of -$0.79 [3/24/2022 7:01 AM] |
21.59 | 0.97 (4.70%) |
20.62 | 0.0 (0.00%) |
11.30 - 37.11 | 48,454 | 108,352 | 265 | ||
| 10-11-2021 | PM | VERA | Vera Therapeutics | 528.00 | -0.36 | -0.60 | 0.00 | Vera Therapeutics reports Q3 results [11/10/2021 9:10 AM] |
23.46 | -1.73 (-6.87%) |
0.0 | 0.0 (0.00%) |
11.30 - 33.45 | 67,121 | 30,000 | 0 | ||
|
||||||||||||||||||
| 16-08-2021 | PM | VERA | Vera Therapeutics, Inc. | 351.00 | -0.33 | -0.39 | 0.00 | Vera Therapeutics EPS in-line [8/16/2021 8:42 AM] |
16.93 | -0.01 (-0.06%) |
0.0 | 0.0 (0.00%) |
11.30 - 26.97 | 2,680 | 10,000 | 0 | ||